UK takes steps to speed up patient access to new treatments in hospitals
This article was originally published in RAJ Devices
Executive Summary
The UK’s health technology assessment body, the National Institute for Health and Clinical Excellence, together with the Department of Health, has proposed new measures to speed up patient access to new health technologies under the government-funded National Health Service1. This includes a consultation on proposed changes to the way that topics (covering pharmaceuticals, biopharmaceuticals, devices and diagnostics) are chosen and referred for NICE’s appraisals of new drugs and treatments2.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.